http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103374021-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103374021-B |
| titleOfInvention | Pyridopyrimidine class HDAC containing zinc binding moiety and mTOR inhibitors |
| abstract | The invention belongs to medical art, be specifically related to the pyridopyrimidines derivatives as HDAC and MTOR inhibitor shown in general formula (I), its pharmacy acceptable salt, and isomer; Wherein A, X, Y, W, L, T, Rn 1 , Rn 2 , Rn 3 , Rn 4 and Rn 5 as in specification sheets define; The invention still further relates to the preparation method of these compounds, the pharmaceutical preparation containing these compounds and pharmaceutical composition, and these compounds treat and/or prevent the application in the medicine of relevant disease active in HDAC and MTOR in preparation. |
| priorityDate | 2012-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 320.